Japan Lifeline will acquire the US company クロスパスキュラー through a share acquisition, making it a wholly owned subsidiary and establishing a foothold in the US market. The acquisition price is reportedly approximately ¥1 billion.
Japan Lifeline announced that it would acquire the US startup クロスパスキュラー through a share acquisition. The transaction will make it a wholly owned subsidiary and is intended to strengthen the company's US operating structure.
The acquisition will be carried out through a Japan Lifeline subsidiary, which will acquire all shares of クロスパスキュラー. The acquisition price is reportedly approximately ¥1 billion, and changes to the capital structure were also announced.
クロスパスキュラー reportedly has FDA-cleared products and holds 4 patents. The company is positioned as a foothold for Japan Lifeline's expansion into the US market, with the transaction expected to strengthen its business base.
Regarding the stock market's reaction after the announcement, some observers said that PTS trading was quiet and the response muted. Future timely disclosures and market reactions are expected to remain in focus.